Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Latent Tuberculosis in Socially Marginalised Citizens

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Reporting to be homeless (independent of whether the person has an official address) or regularly seeking homeless shelters or public institutions to supply basic needs~* LTBI defined by positive IGRA test~* Found plausible by study doctor that the person has been exposed to tuberculosis within 2 years~* Aged 18 years or older~Exclusion Criteria:~* Previously treated for tuberculosis~* Pregnant or breastfeeding~* Active tuberculosis (evaluated by chest x-ray and examination by a trained doctor)~* Unable to give informed consent~* Tested positive for LTBI as part of contact investigation where the index case has or is suspected to have INH of RIF resistant TB~* Known HIV on antiretroviral treatment~* Porphyria~* Known allergy to rifamycins or isoniazid~* Known epilepsy~* Known liver disease causing affected liver parameters (ALAT, alkaline phosphatase, bilirubin, INR)~* Any lab abnormality, disease, concomitant medication or condition that, in the opinion of the investigator, excludes a person from participating

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- RPT-INH (Type: EXPERIMENTAL): Participants treated with weekly rifapentine and isoniazid for twelve weeks.
- control (Type: ACTIVE_COMPARATOR): Participants treated with daily isoniazid for six months

Based on this trial design, predict the completion outcome and termination type (if applicable).